PTC Therapeutics Inc. buy Quitte
Start price
03.03.16
/
50%
€5.86
Target price
05.09.16
€8.03
Performance (%)
21.69%
End price
05.09.16
€7.13
Summary
This prediction ended on 05.09.16 with a price of €7.13. The prediction had a final performance of 21.69%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| PTC Therapeutics Inc. | -0.763% | -0.763% | 79.947% | 90.056% |
| iShares Core DAX® | 2,99 % | 3,22 % | 4,27 % | 53,70 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % | 24,75 % | 76,70 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % | 43,52 % | 60,79 % |
| iShares S&P 500 | -0,01 % | 1,64 % | 20,97 % | 62,81 % |
Comments by Quitte for this prediction
In the thread PTC Therapeutics Inc. diskutieren
chancenreich
die ist nicht so schlecht wie der Absturz vermuten lässt
PTC Therapeutics (NASDAQ: PTCT) recently received a number of ratings updates from brokerages and research firms:
- 3/1/2016 – PTC Therapeutics had its price target raised by analysts at Barclays from $40.00 to $100.00. They now have an “overweight” rating on the stock.
- 3/1/2016 – PTC Therapeutics had its “outperform” rating reaffirmed by analysts at Credit Suisse. They now have a $12.00 price target on the stock, down previously from $36.00. etc etc
(Laufzeit überschritten)